Q4 2025
Released Feb 25, 2026, after the close
10-K filed Feb 26, 2026, 57 days after period end · 0001653477-26-000014
Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$255.10M$255.10M derived+88.1% vs Q4 2024−23.4% vs Q3 2025
Net Income-$84.60M-$84.60M derivedN/M vs Q4 2024N/M vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$87,900,000−20.3%
Operating Cash Flowderived$97,100,000+50.5%
Free Cash Flowderived$73,500,000+85.6%
Margins · derived
Gross margin34.5%−46.9 pt vs Q4 2024
Net margin-33.2%−45.4 pt vs Q4 2024
What the release said
The release
Same quarter
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $255.10M | $135.60M | — | $383.60M |
| Net Income | -$84.60M | $16.60M | -$116.80M | $15.60M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR